Cargando…
Determination of venlafaxine and its active metabolite O-desmethylvenlafaxine in human plasma by HPLC fluorescence
BACKGROUND: Therapeutic drug monitoring guides clinical individualised medication by measuring plasma concentration, which could improve the curative effect, avoid drug overdose and reduce the incidence of adverse reactions. At present, there are few reports on the clinical detection of venlafaxine...
Autores principales: | Shen, Shujuan, Zhang, Chen, Mao, Yemeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6234974/ https://www.ncbi.nlm.nih.gov/pubmed/30582123 http://dx.doi.org/10.1136/gpsych-2018-000010 |
Ejemplares similares
-
Pharmacokinetics of venlafaxine and its major metabolite o-desmethylvenlafaxine in freely moving mice using automated dosing/sampling system
por: Aryal, Bijay, et al.
Publicado: (2012) -
Development and validation of a rapid HPLC- fluorescence method for simultaneous determination of venlafaxine and its major metabolites in human plasma
por: Ardakani, Y. H., et al.
Publicado: (2010) -
Phenolic Esters of O-Desmethylvenlafaxine with Improved Oral Bioavailability and Brain Uptake
por: Zhang, Yang, et al.
Publicado: (2013) -
Advances in Research at Synthesis Process Optimization and Quality Standard Improvement of O-desmethylvenlafaxine Succinate
por: Yang, Shiwei, et al.
Publicado: (2022) -
A Rapid and Sensitive HPLC-Fluorescence Method for Determination of Mirtazapine and Its two Major Metabolites in Human Plasma
por: Lavasani, Hoda, et al.
Publicado: (2014)